EUVIMEDEUVIMED entdecken
Open Access

CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers

Juntao Qi, Gujie Wu, Min He, You Xu, Zheng Yang, Liang Ding, Yan Wang, Zhi Zhang

Aging · 31.01.2024 · 16 (2) · 1879-1896

DOI: 10.18632/aging.205465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, online erschienen am 22.01.2024. Verfasst von Juntao Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen 518000, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cyclin-Dependent Kinase 16 (CDK16) plays significant biological roles in various diseases. Nonetheless, its function in different cancer types and its relationship with the Tumor Immune Microenvironment (TIME) are still not well-understood. METHODS: We analyzed the expression profile, genetic alterations, clinical features, and prognostic value of CDK16 in pan-cancer using data from The Cancer Genome Atlas, Genotype-Tissue Expression databases, and in vitro experiments. Additionally, the TIMER2 and ImmuCellAI databases were utilized to assess the correlation between CDK16 expression and immune cell infiltration levels. Finally, we examined the correlation between CDK16 and the response to immunotherapy using collected immunotherapy data. RESULTS: CDK16 is notably overexpressed in pan-cancer and is a risk factor for poor prognosis in various cancers. Our findings reveal that CDK16 regulates not only cell cycle-related functions to promote cell proliferation but also the autoimmunity-related functions of the innate and adaptive immune systems, along with other immune-related signaling pathways. Moreover, CDK16 overexpression contributes to an immunosuppressive tumor microenvironment, extensively suppressing immune-related features such as the expression of immune-related genes and pathways, as well as the count of immune-infiltrating cells. Our analysis indicated that individuals with low CDK16 expression showed higher response rates to immune checkpoint inhibitors and longer overall survival compared to those with high CDK16 expression. CONCLUSIONS: This study establishes CDK16 as a potential biomarker for predicting poor prognosis in a wide range of cancers. Its role in shaping the immunosuppressive tumor microenvironment and influencing the efficacy of immunotherapy highlights the urgent need for developing targeted therapies against CDK16, offering new avenues for cancer treatment and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsHumansPrognosisGenes, cdcCyclin-Dependent KinasesImmunotherapy

Stichwörter der Autor:innen

CDK16human cancersimmunosuppressive tumor microenvironmentimmunotherapyprognosis

Substanzen

Cyclin-Dependent Kinases

Autor:innen und Institutionen

  • Department of Urology, Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen 518000, China.
  • Department of Health Management, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan 410000, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226000, China.

Zitieren

APA

Qi, J., Wu, G., He, M., Xu, Y., Yang, Z., Ding, L., Wang, Y., & Zhang, Z. (2024). CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers. Aging, 16(2), 1879-1896. https://doi.org/10.18632/aging.205465

Vancouver

Qi J, Wu G, He M, Xu Y, Yang Z, Ding L, et al. CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers. Aging. 2024;16(2):1879-1896. doi:10.18632/aging.205465

BibTeX
@article{Qi2024,
  author = {Qi, Juntao and Wu, Gujie and He, Min and Xu, You and Yang, Zheng and Ding, Liang and Wang, Yan and Zhang, Zhi},
  title = {CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers},
  journal = {Aging},
  year = {2024},
  volume = {16},
  number = {2},
  pages = {1879--1896},
  doi = {10.18632/aging.205465}
}
Kostenlos starten →